menu search

PBYI / Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates

Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates
Puma Biotech's (PBYI) third-quarter 2023 earnings beat estimates, while revenues miss the same. The company tightens the full-year revenue guidance. Read More
Posted: Nov 3 2023, 13:32
Author Name: Zacks Investment Research
Views: 071866

PBYI News  

Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates

By Zacks Investment Research
November 3, 2023

Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates

Puma Biotech's (PBYI) third-quarter 2023 earnings beat estimates, while revenues miss the same. The company tightens the full-year revenue guidance. more_horizontal

Puma Biotechnology, Inc. (PBYI) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 2, 2023

Puma Biotechnology, Inc. (PBYI) Q3 2023 Earnings Call Transcript

Puma Biotechnology, Inc. (NASDAQ:PBYI ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Mariann Ohanesian - Senior D more_horizontal

Puma Biotech (PBYI) Tops Q3 Earnings Estimates

By Zacks Investment Research
November 2, 2023

Puma Biotech (PBYI) Tops Q3 Earnings Estimates

Puma Biotech (PBYI) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to los more_horizontal

PBYI or TECH: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
November 2, 2023

PBYI or TECH: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech (PBYI) and Techne (TECH). But which of these tw more_horizontal

Puma Biotech (PBYI) Loses -18.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

By Zacks Investment Research
October 20, 2023

Puma Biotech (PBYI) Loses -18.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Puma Biotech (PBYI) as it is technically in oversold territory now. In addition to this technical more_horizontal

Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results

By Business Wire
October 19, 2023

Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, Nov. 2, 2023, following the r more_horizontal

Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC

By Zacks Investment Research
September 22, 2023

Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC

Puma's (PBYI) alisertib receives the Orphan Drug designation from the FDA for treating patients with small cell lung cancer. more_horizontal

Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference

By Business Wire
August 31, 2023

Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference

LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach, CEO of Puma Biotechnology, will present a corporate update at the H.C. Wainwright Global Investment Confe more_horizontal


Search within

Pages Search Results: